V1A agonist PHIN-214 shows promise for cirrhosis-associated portal hypertension
Jan. 16, 2024
There are several factors that induce cirrhosis. During cirrhosis, there is an increased intrahepatic resistance to blood flow, leading to portal hypertension, among others, where portal vein pressure is increased.